These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7353378

  • 1. Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy.
    Brickman AS, Coburn JW, Sherrard DJ, Wong EG, Norman AW, Singer FR.
    Contrib Nephrol; 1980; 18():29-41. PubMed ID: 7353378
    [No Abstract] [Full Text] [Related]

  • 2. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
    Malluche HH, Goldstein DA, Massry SG.
    Contrib Nephrol; 1980; 18():98-104. PubMed ID: 7353383
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D, Kraft D, Schaefer K, Krempien B.
    MMW Munch Med Wochenschr; 1974 Sep 13; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract] [Full Text] [Related]

  • 4. A skeletal mineralizing defect in dialysis patients: a syndrome resembling osteomalacia but unrelated to viatamin D.
    Coburn JW, Sherrard DJ, Brickman AS, Wong EG, Norman AW, Singer FR.
    Contrib Nephrol; 1980 Sep 13; 18():172-83. PubMed ID: 7353374
    [No Abstract] [Full Text] [Related]

  • 5. Do parathyroid hormone and 1,25-dithydroxyvitamin D modulate bone formation in uremia?
    Teitelbaum SL, Bergfeld MA, Freitag J, Hruska KA, Slatopolsky E.
    J Clin Endocrinol Metab; 1980 Aug 13; 51(2):247-51. PubMed ID: 6893204
    [No Abstract] [Full Text] [Related]

  • 6. Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure.
    Sherrard DJ, Coburn JW, Brickman AS, Singer FR, Maloney N.
    Contrib Nephrol; 1980 Aug 13; 18():92-7. PubMed ID: 7353382
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy.
    Prior JC, Cameron EC, Ballon HS, Lirenman DS, Moriarty MV, Price JD.
    Am J Med; 1979 Oct 13; 67(4):583-9. PubMed ID: 386792
    [Abstract] [Full Text] [Related]

  • 11. An evaluation of 1 alpha-hydroxy-and 1,25-dihydroxyvitamin D3 in the treatment of renal bone disease.
    Kanis JA, Russell RG, Cundy T, Earnshaw M, Woods CG, Smith R, Heynen G.
    Contrib Nephrol; 1980 Oct 13; 18():12-28. PubMed ID: 7353370
    [Abstract] [Full Text] [Related]

  • 12. The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease.
    Pierides AM, Ellis HA, Simpson W, Cook D, Kerr DN.
    Clin Endocrinol (Oxf); 1977 Dec 13; 7 Suppl():109s-116s. PubMed ID: 606409
    [Abstract] [Full Text] [Related]

  • 13. Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.
    Pierides AM, Ellis HA, Simpson W, Dewar JH, Ward MK, Kerr DN.
    Lancet; 1976 May 22; 1(7969):1092-5. PubMed ID: 57505
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis.
    Ellis HA, Pierides AM, Feest TG, Ward MK, Kerr DN.
    Clin Endocrinol (Oxf); 1977 Dec 22; 7 Suppl():31s-38s. PubMed ID: 606422
    [Abstract] [Full Text] [Related]

  • 16. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
    Teitelbaum SL.
    Ann Intern Med; 1981 Mar 22; 94(3):404-5. PubMed ID: 6894359
    [No Abstract] [Full Text] [Related]

  • 17. 1alpha-Hydroxycholecalciferol in renal osteodystrophy.
    Pierides AM, Ellis HA, Ward MK, Simpson W, Kerr DN.
    Calcif Tissue Res; 1977 May 22; 22 Suppl():105-11. PubMed ID: 912511
    [No Abstract] [Full Text] [Related]

  • 18. Short-term effects of vitamin D3 and 1,25-dihydroxyvitamin D3 on osteomalacia in uremic rats fed a low calcium-low-phosphorus diet.
    Weisbrode SE.
    Am J Pathol; 1981 Jul 22; 104(1):35-40. PubMed ID: 6266257
    [Abstract] [Full Text] [Related]

  • 19. 'One-alpha'.
    Lancet; 1978 May 06; 1(8071):973-4. PubMed ID: 76898
    [No Abstract] [Full Text] [Related]

  • 20. Evidence that different vitamin D sterols have qualitatively different effects in man.
    Rasmussen H, Bordier P.
    Contrib Nephrol; 1980 May 06; 18():184-91. PubMed ID: 7353375
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.